Skip to content

A Study of Invasive Hemodynamic for MACHD Registry

Invasive Hemodynamic Control Cohort for The Mayo Clinic Adult Congenital Heart Disease (MACHD) Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05849025
Enrollment
50
Registered
2023-05-08
Start date
2023-10-16
Completion date
2026-12-01
Last updated
2026-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease, Healthy

Brief summary

This research study is being done to provide comparative data to the Mayo Clinic Adult Congenital Heart Disease Registry.

Interventions

None listed

Sponsors

Mayo Clinic
Lead SponsorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Capacity to Consent * BMI \</= 30 * Systolic BP \</= 140mmHg * Diastolic BP \</= 90 * eGFR \> 30 (within prior 3 months) to confirm kidney function * Able to undergo an MRI

Exclusion criteria

* History of Cardiovascular disease that may affect the results of the testing performed. * Any Current orthopedic limitations * Currently taking any cardiac medication * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Pulmonary vascular reserveBaselineThe slope of mean pulmonary artery pressure / cardiac output (mPAP/CO)

Countries

United States

Contacts

CONTACTACHD Research Program
(507) 293-2565
CONTACTAlexander Egbe, MBBS, MPH
Egbe.Alexander@mayo.edu(507) 284-2520
PRINCIPAL_INVESTIGATORAlexander Egbe, MBBS, MPH

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 6, 2026